RP Management, LLC
- SEC CIK
- 0001507673
- Latest filing
- Aug 6, 2025
Holdings in Q4 2022
Holdings as of Dec 31, 2022, filed Feb 14, 2023. Long positions only; changes compare share counts with Q3 2022.
- Positions
- 3
- 0 vs. Q3 2022
- Portfolio value
- $84.9M
- −$131.5M (−60.8%) vs. Q3 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| BCRXBiocryst Pharmaceuticals Inc | COM | 3,846,154 | $44.2M | 52.0% | 00.0% | Unchanged | History |
| BHVNBiohaven Ltd. | COM | 2,936,507 | $40.8M | 48.0% | +2,936,507 | New | History |
| VIRXViracta Therapeutics, Inc. | COM | 3,700 | $5.40K | <0.1% | 00.0% | Unchanged | History |
Sold out since Q3 2022 (1)
Positions held at the end of Q3 2022 that are gone from this filing.